229 related articles for article (PubMed ID: 17541620)
1. Comparative analysis of the epithelium stroma interaction of acquired middle ear cholesteatoma in children and adults.
Welkoborsky HJ; Jacob RS; Hinni ML
Eur Arch Otorhinolaryngol; 2007 Aug; 264(8):841-8. PubMed ID: 17541620
[TBL] [Abstract][Full Text] [Related]
2. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
[TBL] [Abstract][Full Text] [Related]
4. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
6. Immunobiological peculiarities of cholesteatoma in children: quantification of epithelial proliferation by MIB1.
Bujía J; Holly A; Antolí-Candela F; Tapia MG; Kastenbauer E
Laryngoscope; 1996 Jul; 106(7):865-8. PubMed ID: 8667984
[TBL] [Abstract][Full Text] [Related]
7. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin expression in acquired cholesteatoma.
Erdoglija M; Milanovic N; Colic M; Jovic M
B-ENT; 2013; 9(3):241-6. PubMed ID: 24273956
[TBL] [Abstract][Full Text] [Related]
9. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.
Akimoto R; Pawankar R; Yagi T; Baba S
ORL J Otorhinolaryngol Relat Spec; 2000; 62(5):257-65. PubMed ID: 10965261
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
Lang S; Nerlich A; Wiest I; Schreiner M
Laryngorhinootologie; 1994 Jul; 73(7):371-4. PubMed ID: 7916782
[TBL] [Abstract][Full Text] [Related]
11. Integrin expression in middle ear cholesteatoma.
Dallari S; Cavani A; Bergamini G; Girolomoni G
Acta Otolaryngol; 1994 Mar; 114(2):188-92. PubMed ID: 7515549
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of epithelial proliferation and apoptosis in cholesteatoma of adults].
Olszewska E; Chodynicki S; Chyczewski L
Otolaryngol Pol; 2003; 57(1):85-9. PubMed ID: 12741150
[TBL] [Abstract][Full Text] [Related]
13. Partial Epithelial-Mesenchymal Transition Was Observed Under p63 Expression in Acquired Middle Ear Cholesteatoma and Congenital Cholesteatoma.
Takahashi M; Yamamoto-Fukuda T; Akiyama N; Motegi M; Yamamoto K; Tanaka Y; Yamamoto Y; Kojima H
Otol Neurotol; 2019 Sep; 40(8):e803-e811. PubMed ID: 31348131
[TBL] [Abstract][Full Text] [Related]
14. [The expression of Ras protein in human middle ear cholesteatoma].
Xu Y; Jin K; Dong W
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):74-6. PubMed ID: 12764851
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of proliferating cell nuclear antigen in middle ear cholesteatoma.
Bujia J; Sudhoff H; Holly A; Hildmann H; Kastenbauer E
Eur Arch Otorhinolaryngol; 1996; 253(1-2):21-4. PubMed ID: 8932424
[TBL] [Abstract][Full Text] [Related]
16. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma.
Shinoda H; Huang CC
Eur Arch Otorhinolaryngol; 1995; 252(7):385-90. PubMed ID: 8562031
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proliferative activity in middle ear cholesteatoma using proliferating cell nuclear antigen.
Shieh TJ; Ho KY; Kuo WR; Chai CY; Lin CS; Juan KH
Kaohsiung J Med Sci; 1999 Aug; 15(8):468-74. PubMed ID: 10518363
[TBL] [Abstract][Full Text] [Related]
19. [Markers of epidermal proliferation in middle ear cholesteatoma].
Hassmann-Poznańska E; Skotnicka B; Dziecioł J
Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
[TBL] [Abstract][Full Text] [Related]
20. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]